Experiments for taxon Salvia miltiorrhiza (LAMIACEAE)

Experiments (1232 results)

1232 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
897642	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
998889	PHARMACOLOGY OF EXTRACT - IN VIVO	CIRCULATION STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
642991	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID METABOLISM EFFECTS	Salvia miltiorrhiza (LAMIACEAE)
374753	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,1-2-DIHYDRO:
895425	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENYL CYCLASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID METHYL ESTER
1073087	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	CORONARY VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1174766	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1134771	SPECTROPHOTOMETRIC QUANTIFICATION OF IN		Salvia miltiorrhiza (LAMIACEAE)	LACTIC ACID,BETA-(3-4-DIHYDROXY-PHENYL): D: (+):
497950	PHARMACOLOGY OF EXTRACT - IN VITRO	LYSYL OXIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1105271	PHARMACOLOGY OF EXTRACT - IN VITROCARCINOGENIC DATA (MARKER CODE)	MUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
968712	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
96832	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	ARUCADIOL
421579	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	SUGIOL
1198958	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
889872	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II
981771	PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINQUINONE,METHYLENE:
266512	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	DANSHENXINKUN A,OLEOYL:
374772	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL A
234267	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	SALVIA DITERPENE IISALVIA DITERPENE I
199228	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1300764	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	PHARMACOKINETIC STUDY OF	Salvia miltiorrhiza (LAMIACEAE)
741768	PHARMACOLOGY OF EXTRACT - IN VITRO	CASPASE-3 INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
656861	PHARMACOLOGY OF EXTRACT - IN VITRO	PROLYL ENDOPEPTIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
951268	PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
663410	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE II-A
10817	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
665993	PHARMACOLOGY OF COMPOUND - IN VITRO	HEXOSAMINIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1181141	PHARMACOLOGY OF EXTRACT - IN VITRO	VASOCONSTRICTOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1073029	PHARMACOLOGY OF EXTRACT - IN VIVO	CNS DEPRESSANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
984267	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	DANSHEXINKUN ADANSHEXINKUN BDANSHEXINKUN C
953770	PHARMACOLOGY OF EXTRACT - IN VITRO	HMG-CO-A REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374742	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
663409	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOPROTECTIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1156612	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	MENSTRUATION INDUCTION EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1122408	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
416270	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	MENSTRUATION INDUCTION EFFECT	Salvia miltiorrhiza (LAMIACEAE)
768414	PHARMACOLOGY OF EXTRACT - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
840399	PHARMACOLOGY OF COMPOUND - IN VITROCARCINOGENIC DATA (MARKER CODE)TOXICITY MARKER CODE	MUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II
607520	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
676920	PHARMACOLOGY OF EXTRACT - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1116913	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
670747	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
788244	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
682706	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIVIRAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
374761	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,METHYLENE:
374720	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	PRZEWAQUINONE A
670757	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID
703986	PHARMACOLOGY OF EXTRACT - IN VIVO	PROTECTIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1167319	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
676923	PHARMACOLOGY OF EXTRACT - IN VITRO	GLUTATHIONE DEPLETION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1148323	PRESENT IN (REVIEW)		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1129093	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Salvia miltiorrhiza (LAMIACEAE)
595364	PHARMACOLOGY OF EXTRACT - IN VITRO	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1280026	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
69116	PHARMACOLOGY OF EXTRACT - IN HUMANS	RENAL FUNCTION IMPROVEMENT	Salvia miltiorrhiza (LAMIACEAE)
1288635	PHARMACOLOGY OF EXTRACT - IN VITRO	AROMATASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
104055	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO: ISO:
66830	CLINICAL STUDIES	MISCELLANEOUS EFFECTS	Salvia miltiorrhiza (LAMIACEAE)
374681	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	UTERINE RELAXATION EFFECT	Salvia miltiorrhiza (LAMIACEAE)
780575	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
368336	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II, DIHYDRO:
178758	PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	DANSHENSPIROKETALLACTONE II,EPI:
679872	PHARMACOLOGY OF EXTRACT - IN VIVO	RENIN INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1280037	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
211114	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
746103	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	PROTOCATECHUIC ACIDPROTOCATECHUIC ALDEHYDE
402762	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIDIARRHEAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
758539	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIHYPERTROPHIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1073084	PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS	CORONARY VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
79599	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	DAN-SHEN SPIROKETALLACTONE
897619	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
953769	PHARMACOLOGY OF EXTRACT - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Salvia miltiorrhiza (LAMIACEAE)
670752	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CAFFEIC ACID
895429	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENYL CYCLASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID DIMETHYL ESTER
178490	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	SALVIA SESQUITERPENE 1
1290915	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITRO	DIACYLGLYCEROL ACYLTRANSFERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
117621	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOACETALIDE,EPI:
67676	PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF	PHARMACOKINETIC ALTERATION	Salvia miltiorrhiza (LAMIACEAE)
115937	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	BENZO(B)FURAN-3-CARBALDEHYDE,5-(3-HYDROXY-PROPYL)-7-METHOXY-2-(3'-METHOXY-4'-HYDROXY-PHENYL):
198956	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL B
1277225	PHARMACOLOGY OF COMPOUND - IN VIVO	PHARMACOKINETIC STUDY OF	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
132233	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,DIHYDRO: NOR:
393461	PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID BROSMARINIC ACID
644548	PHARMACOLOGY OF COMPOUND - IN VITRO	MISCELLANEOUS EFFECTS	Salvia miltiorrhiza (LAMIACEAE)	OLEIC ACID
67675	PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF	ANTICOAGULANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
530770	PHARMACOLOGY OF EXTRACT - IN VITRO	MUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
797927	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1153684	EFFECTS DUE TO A COMBINATION OF DRUGSMEDICINAL FOLKLORE REPORTED FOR	CIRCULATION STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
1153632	PHARMACOLOGY OF EXTRACT - IN VITRO	VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1140353	IDENTIFICATION OFQUANTITATIVE DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	TANNIN
951264	PHARMACOLOGY OF EXTRACT - IN VIVO	BARBITURATE POTENTIATION	Salvia miltiorrhiza (LAMIACEAE)
1280044	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
199224	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
514321	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1070730	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Salvia miltiorrhiza (LAMIACEAE)
374783	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL C
711950	PHARMACOLOGY OF EXTRACT - IN VIVO	DNA DAMAGE PREVENTION ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
951813	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIHYPOXIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL C
1190842	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	CAFFEIC ACID TETRAMER,DIHYDRO:
140460	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II,1-HYDROXY:
340820	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	MILTIRONESALVIOL
536704	PHARMACOLOGY OF EXTRACT - IN VIVO	PHARMACOKINETIC STUDY OF	Salvia miltiorrhiza (LAMIACEAE)
1102954	PMR SPECTRUM REPORTEDPLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
948481	PHARMACOLOGY OF EXTRACT - IN VIVO	ALLOGRAFT REJECTION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
861836	QUANTITATIVE DATAIDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,METHYLENE:
380472	PHARMACOLOGY OF EXTRACT - IN VIVO	GENE EXPRESSION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1105274	PHARMACOLOGY OF EXTRACT - IN VITROCARCINOGENIC DATA (MARKER CODE)	MUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1129094	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Salvia miltiorrhiza (LAMIACEAE)
1093570	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
263394	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)	PHENYL-2(R)-LACTAMIDE,3-(3'-4'-DIHYDROXY-PHENYL):
944822	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP LEVELS INCREASED	Salvia miltiorrhiza (LAMIACEAE)	TRANSHINONE VI
374724	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
682702	PHARMACOLOGY OF COMPOUND - IN VITRO	HIV-1 INTEGRASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID
1116905	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	PHENANTHRENE-3-4-DIONE,2-ISO-PROPYL-8-METHYL:
374716	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	PRZEWAQUINONE A
665541	PHARMACOLOGY OF EXTRACT - IN VITRO	NITRIC OXIDE SCAVENGING ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
663418	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LACTAMIDE,3-(3-4-DIHYDROXY-PHENYL):
367070	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID A,ACETYL:
565140	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
520689	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
130101	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID E
897631	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
1147540	MEDICINAL FOLKLORE REPORTED FOR	ANTICOAGULANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
956669	PHARMACOLOGY OF EXTRACT - IN VIVO	RADIOPROTECTIVE EFFECT	Salvia miltiorrhiza (LAMIACEAE)
711949	PHARMACOLOGY OF EXTRACT - IN VIVO	DNA ADDUCT FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374705	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
639384	PHARMACOLOGY OF EXTRACT - IN VITRO	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
757321	PHARMACOLOGY OF EXTRACT - IN VIVO	CHOLESTEROL LEVEL DECREASE	Salvia miltiorrhiza (LAMIACEAE)
897620	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
374731	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
724776	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-ATANSHINONE ICRYPTOTANSHINONE
843901	PHYTOCHEMICAL SCREENING FORQUANTITATIVE DATACOLORIMETRIC ASSAY FOR		Salvia miltiorrhiza (LAMIACEAE)	O
741656	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)	LACTAMIDE,3-(3-4-DIHYDROXY-PHENYL): 2(R):
69275	PHARMACOLOGY OF EXTRACT - IN HUMANS	GLUTATHIONE PEROXIDASE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
1168722	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTITHYROTROPIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1280033	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
263391	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	SALVIAMILTAMIDE
704295	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1087450	PHARMACOLOGY OF EXTRACT - IN HUMANS	RENAL FUNCTION IMPROVEMENT	Salvia miltiorrhiza (LAMIACEAE)
1167326	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
973323	PHARMACOLOGY OF EXTRACT - IN VIVO	CHROMOSOME ABERRATIONS INDUCED	Salvia miltiorrhiza (LAMIACEAE)
1153685	EFFECTS DUE TO A COMBINATION OF DRUGSMEDICINAL FOLKLORE REPORTED FOR	CNS STIMULANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
918643	PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE VI
932510	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
949172	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1304230	EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES	IMMUNOMODULATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
780574	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
597831	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTICEREBRAL EDEMA ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
934914	PHARMACOLOGY OF EXTRACT - IN VITRO	CHRONOTROPIC EFFECT NEGATIVE	Salvia miltiorrhiza (LAMIACEAE)
641388	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
374782	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL C
374713	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL A
362532	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1277224	PHARMACOLOGY OF COMPOUND - IN VIVO	PHARMACOKINETIC STUDY OF	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
473434	PHARMACOLOGY OF EXTRACT - IN VITRO	COMPLEMENT INDUCTION EFFECT	Salvia miltiorrhiza (LAMIACEAE)
476593	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
549138	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1191255	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIRADIATION EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1290921	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
943058	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374771	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL A
935212	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTISHOCK EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1319935	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOREFFECTS DUE TO A COMBINATION OF DRUGS	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
758538	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
418078	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID
300657	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
670748	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
1167323	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
96835	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	SALVIOXIDE,NOR:
951817	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIHYPOXIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
374787	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONIC ACID METHYL ESTER
968708	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1143141	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,METHYLENE:
374727	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,15-16-DIHYDRO:
109450	CMR SPECTRUM REPORTEDCOMPLETE SYNTHESIS REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SUGIOL
1190965	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINQUINONE,1-2-DIHYDRO:TANSHINONE ITANSHINONE I,DIHYDRO:CRYPTOTANSHINONE
1317242	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
670762	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
113689	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIOLONE
374702	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1086911	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
981772	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-ATANSHINONE ITANSHINONE EE-BSITOSTEROL,BETA:TANSHINONATE,METHYL:CRYPTOTANSHINONETANSHINONE,DIHYDRO: (-):
1143146	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL B
671421	PHARMACOLOGY OF EXTRACT - IN VIVO	CNS DEPRESSANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1303341	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIATHEROGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
782631	PHARMACOLOGY OF EXTRACT - IN VITRO	COLLAGEN SYNTHESIS INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
802757	PHARMACOLOGY OF EXTRACT - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
934912	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOLYTIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
703296	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEASE(HIV) INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374738	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
607519	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
1141943	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	URSOLIC ACIDPROTOCATECHUIC ALDEHYDETANSHINONE I,DIHYDRO:FERULIC ACID,ISO:SITOSTEROL,BETA:CRYPTOTANSHINONEDAUCOSTEROLBAICALIN
1070729	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	UTERINE RELAXATION EFFECT	Salvia miltiorrhiza (LAMIACEAE)
374693	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE,DEHYDRO:
374760	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,METHYLENE:
897637	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
771001	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
601041	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
953771	PHARMACOLOGY OF EXTRACT - IN VITRO	CALCIUM CHANNEL BLOCKER	Salvia miltiorrhiza (LAMIACEAE)
497947	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
929502	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE,1-DEHYDRO:
968719	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
680855	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOCHROME P450 INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
718954	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
675905	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIAMNESIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374749	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL B
807744	PHARMACOLOGY OF EXTRACT - IN VIVO	ALCOHOL INTAKE DECREASE	Salvia miltiorrhiza (LAMIACEAE)
109708	X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	FURO(3,2-C)NAPHTH(2,1-E)OXEPINE-10-12-DIONE,6-7-8-9-TETRAHYDRO: 1-6-6-TRIMETHYL:
595491	PHARMACOLOGY OF EXTRACT - IN VIVO	NITRIC OXIDE RELEASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
198955	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL A
421585	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOLSALVILENONE
663407	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
198963	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,1-2-DIHYDRO:
211120	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHEXINKUN A,(-):
1080991	PRESENT IN (REVIEW)PHARMACOLOGY OF COMPOUND - IN HUMANS	ANTIANGINAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
953003	PHARMACOLOGY OF EXTRACT - IN VIVO	ALKALINE PHOSPHATASE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
492262	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
367072	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN E-2 RELEASE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID A,ACETYL:
130100	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID D
602023	PHARMACOLOGY OF COMPOUND - IN VITRO	SPASMOLYTIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	BLECHINIC ACID,8-EPI:
522213	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
832024	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINOLIDE
1153629	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOTENSIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
351248	PHARMACOLOGY OF EXTRACT - IN VITRO	RNA REVERSE TRANSCRIPTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
840456	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	LACTIC ACID,BETA-(3-4-DIHYDROXY-PHENYL): (+):
779922	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
198970	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL A
789017	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
199218	UV SPECTRUM GIVEN FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	DANSHENOL A
873964	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	PROTOCATECHUIC ACIDPROTOCATECHUIC ALDEHYDEDANSHENSU
350897	PHARMACOLOGY OF EXTRACT - IN VITRO	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
91626	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHENSPIROKETALLACTONE
421574	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,NOR:
663408	PHARMACOLOGY OF COMPOUND - IN VITRO	FREE RADICAL FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
897626	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
932515	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINQUINONE,METHYLENE:
663414	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID,DIMETHYL:
374697	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
374776	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL B
634802	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
942075	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
584266	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
1116322	IDENTIFICATION IN BY PAPER CHROMATOGRAPHY		Salvia miltiorrhiza (LAMIACEAE)	TANNIN
968716	PHARMACOLOGY OF COMPOUND - IN VITRO	COMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
497951	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
807684	PHARMACOLOGY OF COMPOUND - IN VITRO	TYROSINASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID
1153731	EFFECTS DUE TO A COMBINATION OF DRUGSMEDICINAL FOLKLORE REPORTED FOR	BLOOD SYSTEM EFFECTS(UNSPECIFIED)	Salvia miltiorrhiza (LAMIACEAE)
758307	PHARMACOLOGY OF EXTRACT - IN VITRO	NUCLEAR FACTOR KAPPA-BETA INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
951257	PHARMACOLOGY OF EXTRACT - IN VITRO	DNA SYNTHESIS STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
140459	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINQUINONE,3-ALPHA-HYDROXY-METHYLENE:
73204	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	SALVILENONE
1280022	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
889877	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
802477	PHARMACOLOGY OF EXTRACT - IN VITRO	CELL GROWTH ENHANCEMENT EFFECT	Salvia miltiorrhiza (LAMIACEAE)
104056	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,ISO: DIHYDRO:
10816	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1143142	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
1007783	PHARMACEUTICAL FORMULATION OF		Salvia miltiorrhiza (LAMIACEAE)
368332	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE I
738995	PHARMACOLOGY OF EXTRACT - IN VIVO	PLASMINOGEN ACTIVATOR INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374686	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
821443	MEDICINAL FOLKLORE REPORTED FOR	ANTIANGINAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
103082	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	SALVINONE
1158313	PHARMACOLOGY OF EXTRACT - IN VITRO	PLAQUE FORMATION SUPPRESSANT	Salvia miltiorrhiza (LAMIACEAE)
680148	PHARMACOLOGY OF EXTRACT - IN VITRO	RECEPTOR BINDING STIMULANT	Salvia miltiorrhiza (LAMIACEAE)
374765	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,3-HYDROXY-METHYLENE:
1306262	IDENTIFICATION IN BY HPLCWORK INVOLVES DEVELOPMENT OF MARKER COMPOUNDS FOR CHEMICAL STANDARDIZATION OF EXTRACT		Salvia miltiorrhiza (LAMIACEAE)	CAFFEIC ACIDSALVIANOLIC ACID BPROTOCATECHUIC ALDEHYDESALVIANOLIC ACID ASALVIANOLIC ACID DROSMARINIC ACIDDANSHENSU
211124	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	SUGIOL
602020	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	BLECHINIC ACID,8-EPI:
438243	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	SPERM MOTILITY INCREASED	Salvia miltiorrhiza (LAMIACEAE)
1073028	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTICONVULSANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
840398	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II
453819	PHARMACOLOGY OF EXTRACT - IN HUMANS	CARDIOTONIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1170917	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
473707	IDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
808305	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
1116906	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	PHENANTHRENE-3-4-DIONE,2-ISO-PROPYL-8-METHYL:
663419	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)	LACTAMIDE,3-(3-4-DIHYDROXY-PHENYL):
104049	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHENSPIROKETALLACTONE
1190969	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE IITANSHINQUINONE,METHYLENE:
595406	MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLCTLC DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,METHYLENE:TANSHINONE II-ATANSHINONE ICRYPTOTANSHINONE
663420	PHARMACOLOGY OF COMPOUND - IN VITRO	FREE RADICAL FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LACTAMIDE,3-(3-4-DIHYDROXY-PHENYL):
1198775	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTINEPHROTOXIC	Salvia miltiorrhiza (LAMIACEAE)
211113	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	DANSHENOL B
663403	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
371798	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIATHEROSCLEROTIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
116398	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE,NEO: DEOXY:
932517	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
1301396	PHARMACOLOGY OF EXTRACT - IN VITRO	APOPTOSIS INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
989779	MEDICINAL FOLKLORE REPORTED FORREVIEW OF	ANTIANGINAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
968705	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
104054	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
374773	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL A
211117	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
951809	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIHYPOXIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL A
1288634	PHARMACOLOGY OF EXTRACT - IN VITRO	ETHOXYCOUMARIN DEETHYLASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
948483	PHARMACOLOGY OF EXTRACT - IN VIVO	ALLOGRAFT REJECTION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
951265	PHARMACOLOGY OF EXTRACT - IN VIVO	BARBITURATE POTENTIATION	Salvia miltiorrhiza (LAMIACEAE)
1280043	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
808302	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,DIHYDRO:
1177546	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTICOAGULANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1290916	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE IIATANSHINONE ITANSHINONE I,15-16-DIHYDRO:CRYPTOTANSHINONE
489785	IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGY		Salvia miltiorrhiza (LAMIACEAE)	PROTOCATECHUALDEHYDE
788867	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-ATANSHINONE ITANSHINONE I,DIHYDRO:CRYPTOTANSHINONE
426802	EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS	HAIR STIMULANT EFFECT	Salvia miltiorrhiza (LAMIACEAE)
776936	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
984266	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINOIC ACID METHYL ESTERTANSHINONE II-ATANSHINONE ITANSHINONE I,DIHYDRO:TANSHINONE II-A,HYDROXY:TANSHINONE II-BCRYPTOTANSHINONE
374767	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,3-HYDROXY-METHYLENE:
1280036	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
741655	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LACTAMIDE,3-(3-4-DIHYDROXY-PHENYL): 2(R):
571124	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID BSALVIANOLIC ACID AROSMARINIC ACIDSALVIANOLIC ACID C
492264	PHARMACOLOGY OF COMPOUND - IN SITU	HYPOTENSIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
973324	PHARMACOLOGY OF EXTRACT - IN VIVO	CLASTOGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
565139	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
250973	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	NEOCRYPTOTANSHINONE II
1115492	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	PSORIASIS TREATMENT	Salvia miltiorrhiza (LAMIACEAE)
1153734	PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSREVIEW OF	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1208110	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERTENSIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
377609	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374752	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,1-2-DIHYDRO:
929500	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIA COMPOUND RO-090680
374747	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL B
140461	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II,1-HYDROXY:
75375	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	DANSHENXINKUN D
67851	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTITHROMBOTIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
802481	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN EXPRESSION STIMULATION	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
115936	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	BENZO(B)FURAN-3-CARBALDEHYDE,5-(3-HYDROXY-PROPYL)-7-METHOXY-2-(3'-METHOXY-4'-HYDROXY-PHENYL):
1198955	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374762	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,3-HYDROXY-METHYLENE:
680145	PHARMACOLOGY OF EXTRACT - IN VITRO	RECEPTOR BINDING STIMULANT	Salvia miltiorrhiza (LAMIACEAE)
104052	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
374730	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
958398	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	IMMUNOSUPPRESSANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
362119	PHARMACOLOGY OF EXTRACT - IN VIVO	APOPTOSIS INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
665987	PHARMACOLOGY OF EXTRACT - IN VITRO	HEXOSAMINIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
663415	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID,DIMETHYL:
346750	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	DRUG INTERACTION	Salvia miltiorrhiza (LAMIACEAE)
897627	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
374680	MEDICINAL FOLKLORE REPORTED FOR	HEMOSTATIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1158314	PHARMACOLOGY OF EXTRACT - IN VITRO	PLAQUE FORMATION SUPPRESSANT	Salvia miltiorrhiza (LAMIACEAE)
69386	PHARMACOLOGY OF EXTRACT - IN HUMANS	PHARMACOKINETIC STUDY OF	Salvia miltiorrhiza (LAMIACEAE)
1202722	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
897640	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
741763	PHARMACOLOGY OF EXTRACT - IN VITRO	GLUTATHIONE FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
665985	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
741661	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B DIMETHYL ESTER
889880	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE VI
925781	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
453818	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	CARDIOTONIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
788243	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
663404	PHARMACOLOGY OF COMPOUND - IN VITRO	FREE RADICAL FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
178759	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINLACTONE,DIHYDRO:
374778	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL B
377612	PHARMACOLOGY OF EXTRACT - IN VIVO	MYELOPEROXIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
713428	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	PROTOCATECHUALDEHYDEPROTOCATECHUIC ACIDLACTIC ACID,OMEGA-(3-4-DIHYDROXY-PHENYL):
374741	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
800597	PHARMACOLOGY OF EXTRACT - IN VIVO	APOPTOSIS INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
505133	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
861837	QUANTITATIVE DATAIDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
374709	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL A
380471	PHARMACOLOGY OF EXTRACT - IN VIVO	NOS INDUCTION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
113687	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIOPOLONE
348300	PHARMACOLOGY OF EXTRACT - IN HUMANS	TOXIC EFFECT(GENERAL)	Salvia miltiorrhiza (LAMIACEAE)
733981	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
490483	PLANT TISSUE CULTURE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-ATANSHINONE ICRYPTOTANSHINONE
100900	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,AMMONIUM-POTASSIUM:
1102953	PMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOL
1317244	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIPANCREATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
1116914	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
374789	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONIC ACID METHYL ESTER
368333	MASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
777948	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	DRUG INTERACTION	Salvia miltiorrhiza (LAMIACEAE)
1297382	PHARMACOLOGY OF EXTRACT - IN VIVO	MYOCARDIAL ISCHEMIC IMPROVEMENT	Salvia miltiorrhiza (LAMIACEAE)
1093573	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIHYPOXIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
89507	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHEXINKUN A
644549	PHARMACOLOGY OF COMPOUND - IN VITRO	MISCELLANEOUS EFFECTS	Salvia miltiorrhiza (LAMIACEAE)	PALMITIC ACID
1280025	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
821444	MEDICINAL FOLKLORE REPORTED FOR	ANTICOAGULANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1143148	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A,3-ALPHA-HYDROXY:
729305	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEIN KINASE C INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
595361	PHARMACOLOGY OF EXTRACT - IN VITRO	MEMBRANE FLUIDITY INCREASED	Salvia miltiorrhiza (LAMIACEAE)
1153631	PHARMACOLOGY OF EXTRACT - IN VITRO	CORONARY BLOOD FLOW INCREASED	Salvia miltiorrhiza (LAMIACEAE)
497270	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
771003	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIVIRAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
660749	PHARMACOLOGY OF EXTRACT - IN VITRO	INTERCELLULAR COMMUNICATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
489455	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1147541	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTICOAGULANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
636110	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
886999	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-ACRYPTOTANSHINONE
363789	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTINEPHROTOXIC	Salvia miltiorrhiza (LAMIACEAE)
889875	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
968713	PHARMACOLOGY OF EXTRACT - IN VITRO	COMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
788851	PHARMACOLOGY OF EXTRACT - IN VITRO	CELL ADHESION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
629099	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIALCOHOLIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
951269	PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1280032	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
354272	PHARMACOLOGY OF EXTRACT - IN VITRO	ANGIOTENSIN-II INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1143140	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
374758	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,METHYLENE:
642990	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID METABOLISM EFFECTS	Salvia miltiorrhiza (LAMIACEAE)
367073	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN INDUCTION	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID A,ACETYL:
1286485	EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES	IMMUNOMODULATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1311737	PRESENT IN (REVIEW)		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1117379	MEDICINAL FOLKLORE REPORTED FOR	CIRCULATION STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
377607	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
895426	CMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID MONOMETHYL ESTER
682701	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID
109709	PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	SALVIA DITERPENE LACTONE 6SALVIA DITERPENE LACTONE 5
473435	PHARMACOLOGY OF EXTRACT - IN HUMANS	COMPLEMENT INDUCTION EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1211228	QUANTITATIVE DATAIDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	FLUORIDE
374723	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
263393	UV SPECTRUM GIVEN FORQUANTITATIVE DATACD SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	PHENYL-2(R)-LACTAMIDE,3-(3'-4'-DIHYDROXY-PHENYL):
96831	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	SALVIOLONE
601040	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
374706	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
130102	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMATE,ETHYL:
374717	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	PRZEWAQUINONE A
67674	PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF	DRUG INTERACTION	Salvia miltiorrhiza (LAMIACEAE)
266511	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	DANSHENXINKUN A,OLEOYL:
779924	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Salvia miltiorrhiza (LAMIACEAE)
374734	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,15-16-DIHYDRO:
198967	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,HYDROXY-METHYL:
178760	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHENSPIROKETALLACTONE
711948	PHARMACOLOGY OF EXTRACT - IN VIVO	ALANINE AMINOTRANSFERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
514322	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
741767	PHARMACOLOGY OF EXTRACT - IN VITRO	REACTIVE OXYGEN SPECIES GENERATION STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
234266	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE ICRYPTOTANSHINONE
374725	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
977811	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANNIN
1181140	PHARMACOLOGY OF EXTRACT - IN VITRO	VASOCONSTRICTOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
780576	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374784	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL C
1087628	PHARMACOLOGY OF EXTRACT - IN VITRO	FIBRINOLYTIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1143139	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL A
198960	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
951258	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTAMATE-OXALOACETATE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
680150	PHARMACOLOGY OF EXTRACT - IN VITRO	RECEPTOR BINDING STIMULANT	Salvia miltiorrhiza (LAMIACEAE)
758263	PHARMACOLOGY OF EXTRACT - IN VITRO	NITRIC OXIDE SYNTHASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1153730	EFFECTS DUE TO A COMBINATION OF DRUGSMEDICINAL FOLKLORE REPORTED FOR	CIRCULATION STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
453820	PHARMACOLOGY OF EXTRACT - IN HUMANS	CARDIAC OUTPUT INCREASED	Salvia miltiorrhiza (LAMIACEAE)
968720	PHARMACOLOGY OF COMPOUND - IN VITRO	COMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
670746	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
116400	CMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
962897	PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID MG SALT
680606	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIBODY FORMATION SUPPRESSION	Salvia miltiorrhiza (LAMIACEAE)
198971	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL B
757216	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1167318	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
897638	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
117622	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHENSPIROKETALLACTONE
374688	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
132234	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,DIHYDRO: METHYL:
374736	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,15-16-DIHYDRO:
67677	PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF	PHARMACOKINETIC ALTERATION	Salvia miltiorrhiza (LAMIACEAE)
497948	PHARMACOLOGY OF EXTRACT - IN VITRO	COLLAGEN BIOSYNTHESIS INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
929501	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	SALVIA COMPOUND RO-090680
680856	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOCHROME P450 INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
104046	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	MILTIONONE I
694211	PHARMACOLOGY OF EXTRACT - IN VIVO	ANGIOGENESIS INDUCTION	Salvia miltiorrhiza (LAMIACEAE)
496087	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR		Salvia miltiorrhiza (LAMIACEAE)	PROTOCATECHUALDEHYDE
10818	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
198959	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
211112	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
421582	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVILENONE
1185360	PHARMACOLOGY OF EXTRACT - IN VIVO	DIURETIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1117380	PHARMACOLOGY OF EXTRACT - IN VIVO	MYOCARDIAL UPTAKE OF 86-RB ENHANCED	Salvia miltiorrhiza (LAMIACEAE)
89511	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B,ISO:
951816	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
808309	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
968707	PHARMACOLOGY OF EXTRACT - IN VITRO	COMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
140458	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINQUINONE,3-ALPHA-HYDROXY-METHYLENE:
1190964	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINQUINONE,1-2-DIHYDRO:TANSHINONE ITANSHINONE I,DIHYDRO:CRYPTOTANSHINONE
1156611	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	ABORTIFACIENT EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1024430	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPOXIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	LACTIC ACID,BETA-(3-4-DIHYDROXY-PHENYL): D: (+):
1073085	PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS	CORONARY VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
92799	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
802760	PHARMACOLOGY OF EXTRACT - IN VITRO	BENZODIAZEPINE BINDING STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
374712	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL A
346355	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
199222	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	DANSHENOL B
440064	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
437783	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Salvia miltiorrhiza (LAMIACEAE)	PROTOCATECHUALDEHYDE
91625	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	DANSHENSPIROKETALLACTONE,EPI:
629100	PHARMACOLOGY OF EXTRACT - IN VIVO	MISCELLANEOUS EFFECTS	Salvia miltiorrhiza (LAMIACEAE)
665540	PHARMACOLOGY OF EXTRACT - IN VITRO	NITRIC OXIDE RELEASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
962294	QUANTITATIVE DATAIDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
797926	PHARMACOLOGY OF EXTRACT - IN VITRO	FREE RADICAL FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
73206	MEDICINAL FOLKLORE REPORTED FOR	HEMOSTATIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
300656	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,1-2-DIHYDRO:
300654	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Salvia miltiorrhiza (LAMIACEAE)	DANSHENXINKUN A,ACETYL:
1116909	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
116395	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	DANSHEXINKUN S,(-):
211123	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SUGIOL
374770	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL A
670761	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
103085	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
663396	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
895422	CMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID
69130	REVIEW OF		Salvia miltiorrhiza (LAMIACEAE)
1167320	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
671420	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Salvia miltiorrhiza (LAMIACEAE)
151168	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	TROPONO[2,3-C]-7-7-DIMETYL-12-OXA-TRICYCLO[4,4,2(1,4),0]-DODECANE,16-METHYL:
374728	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
374788	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONIC ACID METHYL ESTER
729304	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
1178030	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	ANTINEPHRITIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
639382	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
953004	PHARMACOLOGY OF EXTRACT - IN VIVO	PLASMA BILIRUBIN DECREASE	Salvia miltiorrhiza (LAMIACEAE)
807685	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID METHYL ESTER
1303404	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
929497	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
703295	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEASE(HIV) INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
716002	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERTENSIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
441251	PRESENT IN (REVIEW)		Salvia miltiorrhiza (LAMIACEAE)	ARUCADIOLTANSHINDIOL ATANSHINONE,7-DEHYDRO:FLAVANONE,3-3'-5-TRIHYDROXY-4'-7-DIMETHOXY:FERRUGINOLSALVIOLONETANSHINONE II-B,ISO:CRYPTOTOANSHINONE,ISO:MILTIRONETANSHINONE,NOR:CRYPTOTANSHINONE,NEO:TANSHINONE II-ATANSHINLACTONETANSHINONE IDANSHEXINKUN DSALVIOXIDE,NOR:TANSHINONE I,ISO:TANSHINONE II,ISO:TANSHINONE I,DIHYDRO:TANSHINDIOL CDANSHEXINKUN ADANSHEXINKUN BTANSHINONE,HYDROXY:TANSHINONE II-BMILTIRONE,7-DEHYDRO:CRYPTOTANSHINONESALVIOLSALVINONETANSHINDIOL BTANSHINONIC ACID METHYL ESTER
374701	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
1143147	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL C
374735	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,15-16-DIHYDRO:
665988	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
1007968	PHARMACOLOGY OF EXTRACT - IN VITRO	PHOSPHODIESTERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374699	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
918642	PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE VI
1130855	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DAN SHEN SUAN CDAN SHEN SUAN ADAN SHEN SUAN B
1181144	PHARMACOLOGY OF EXTRACT - IN VITRO	VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1024429	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	LACTIC ACID,BETA-(3-4-DIHYDROXY-PHENYL): D: (+):
374781	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL C
897630	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
1181143	PHARMACOLOGY OF EXTRACT - IN VITRO	VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
805970	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1235182	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	ABORTIFACIENT EFFECT	Salvia miltiorrhiza (LAMIACEAE)
960907	PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
968718	PHARMACOLOGY OF COMPOUND - IN VITRO	COMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
1122358	PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS	PHOSPHODIESTERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374777	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL B
932514	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)
808306	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
686493	PHARMACOLOGY OF EXTRACT - IN VITRO	LEUKOCYTE PROLIFERATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
368338	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	PHENANTHRENE-9-10-DIONE
199225	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
362535	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
960060	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	PROTOCATECHUALDEHYDEDANSHENSU
679870	PHARMACOLOGY OF EXTRACT - IN VIVO	ANGIOTENSIN-CONVERTING ENZYME INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
514319	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
932516	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
104050	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHEXINKUN B
497954	PHARMACOLOGY OF COMPOUND - IN VITRO	PROLINE HYDROXYLASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
807743	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
951811	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIHYPOXIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL B
889876	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
897622	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
781707	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIANIC ACID
561027	PHARMACOLOGY OF EXTRACT - IN VITRO	CELL PROLIFERATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1160237	MEDICINAL FOLKLORE REPORTED FOR	LIVER EFFECTS(UNSPECIFIED)	Salvia miltiorrhiza (LAMIACEAE)
1141942	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO: ISO:
1143145	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,NOR:
680149	PHARMACOLOGY OF EXTRACT - IN VITRO	RECEPTOR BINDING STIMULANT	Salvia miltiorrhiza (LAMIACEAE)
374746	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL B
1070728	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	UTERINE STIMULANT EFFECT	Salvia miltiorrhiza (LAMIACEAE)
85183	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINLACTONE
1158315	PHARMACOLOGY OF EXTRACT - IN VITRO	PLAQUE FORMATION SUPPRESSANT	Salvia miltiorrhiza (LAMIACEAE)
663399	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)
374757	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,METHYLENE:
1128881	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYSPECTROPHOTOMETRIC QUANTIFICATION OF IN		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
951262	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374766	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,3-HYDROXY-METHYLENE:
771002	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIVIRAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
400035	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
496090	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
935211	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTISHOCK EFFECT	Salvia miltiorrhiza (LAMIACEAE)
374698	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
266507	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTASHINONE,NEO: OLEOYL:
515884	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
750334	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
639385	PHARMACOLOGY OF EXTRACT - IN VITRO	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
69278	PHARMACOLOGY OF EXTRACT - IN HUMANS	LAMININ INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
422497	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
758308	PHARMACOLOGY OF EXTRACT - IN VITRO	COLLAGEN BIOSYNTHESIS INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
670753	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID
788240	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
374739	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL B
665992	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
438669	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENYL CYCLASE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
934913	PHARMACOLOGY OF EXTRACT - IN VITRO	INOTROPIC EFFECT POSITIVE	Salvia miltiorrhiza (LAMIACEAE)
802478	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
897641	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
895423	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENYL CYCLASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID
768413	PHARMACOLOGY OF EXTRACT - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1190596	PHARMACOLOGY OF EXTRACT - IN HUMANS	CARDIOVASCULAR EFFECTS(UNSPECIFIED)	Salvia miltiorrhiza (LAMIACEAE)
1149773	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
351247	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIVIRAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1167325	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374692	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE,DEHYDRO:
850949	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	BENZALDEHYDE,3-4-DIHYDROXY:
374687	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
789597	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Salvia miltiorrhiza (LAMIACEAE)	MELATONIN
1280021	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
804351	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
751807	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERTENSIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID BLITHOSPERMIC ACID B,MAGNESIUM:
676013	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
250974	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	ABIETA-5-8-11-13-TETRAEN-7-ONE,6-12-DIHYDROXY:
802759	PHARMACOLOGY OF EXTRACT - IN VITRO	SEROTONIN (5-HT) RECEPTOR BINDING ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
438668	IDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
235549	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	SALVIA DITERPENE RO-09-0680
665539	PHARMACOLOGY OF EXTRACT - IN VITRO	NITRIC OXIDE RELEASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
514320	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
368334	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIOXIDANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
538378	PHARMACOLOGY OF EXTRACT - IN HUMANS	PHARMACOKINETIC STUDY OF	Salvia miltiorrhiza (LAMIACEAE)
676922	PHARMACOLOGY OF EXTRACT - IN VITRO	REACTIVE OXYGEN SPECIES GENERATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
682700	PHARMACOLOGY OF EXTRACT - IN VITRO	DEHYDROFOLATE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
109448	PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPLETE SYNTHESIS REPORTED		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,1-2-5-6-TETRAHYDRO:TANSHINONE,FORMYL:SALVIA TANSHINONE 33MILTIRONE,4-METHYLENE:SALVIA TANSHINONE 37ABIETA-8-13-DIENE-11-12-DIONE,7-BETA-HYDROXY:SALVIA TANSHINONE 31TANSHINQUINONE,DIHYDRO: METHYLENESALVIA TANSHINONE 32
1116907	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II
897634	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
1070727	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Salvia miltiorrhiza (LAMIACEAE)
470022	PHARMACOLOGY OF COMPOUND - IN VITRO	SPASMOLYTIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
793592	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBODY FORMATION SUPPRESSION	Salvia miltiorrhiza (LAMIACEAE)
802480	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL DIFFERENTIATION INDUCTION	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
680146	PHARMACOLOGY OF EXTRACT - IN VITRO	RECEPTOR BINDING STIMULANT	Salvia miltiorrhiza (LAMIACEAE)
680857	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOCHROME P450 INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1280028	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
901321	COMPLETE SYNTHESIS REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIOLONE
897633	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
729306	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEIN KINASE C INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
779925	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Salvia miltiorrhiza (LAMIACEAE)
104053	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,DIHYDRO:
718956	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
506028	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
497949	PHARMACOLOGY OF EXTRACT - IN VITRO	PROLINE HYDROXYLASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
116402	CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE,NEO:
951808	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL A
1024453	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	CIRCULATION STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
802476	PHARMACOLOGY OF EXTRACT - IN VITRO	CELL DIFFERENTIATION INDUCTION	Salvia miltiorrhiza (LAMIACEAE)
453817	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	CARDIAC OUTPUT INCREASED	Salvia miltiorrhiza (LAMIACEAE)
476919	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
151167	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	BENZO[2,3-A]-7-7-DIMETHYL-12-OXA-TRICYCLO[4,4,2(1,4),0]-DODECANE,13-14-DIHYDROXY-15-METHYL:
1116911	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,1-2-DIHYDRO:
776937	PHARMACOLOGY OF EXTRACT - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1303234	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE IIA
377613	PHARMACOLOGY OF EXTRACT - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
198961	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE,DEHYDRO:
577821	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
571125	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIOXIDANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID BSALVIANOLIC ACID AROSMARINIC ACIDSALVIANOLIC ACID C
733980	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
351250	PHARMACOLOGY OF EXTRACT - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
808308	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
100901	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIUREMIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,AMMONIUM-POTASSIUM:
918645	PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE V
374729	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1290917	PHARMACOLOGY OF COMPOUND - IN VITRO	DIACYLGLYCEROL ACYLTRANSFERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE IIATANSHINONE I
198972	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL C
1007418	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	LACTIC ACID,BETA-(3-4-DIHYDROXY-PHENYL): D: (+):
140462	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONIC ACID METHYL ESTER
644546	PHARMACOLOGY OF COMPOUND - IN VITRO	MISCELLANEOUS EFFECTS	Salvia miltiorrhiza (LAMIACEAE)	LINOLENIC ACID
1081186	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIAGGLUTININ ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
968710	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
807239	PHARMACOLOGY OF COMPOUND - IN VITRO	BONE RESORPTION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
663400	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)
198964	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONATE,METHYL:
1198956	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1140209	PHARMACOLOGY OF EXTRACT - IN HUMANS	VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
67673	PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF	PHARMACOKINETIC ALTERATION	Salvia miltiorrhiza (LAMIACEAE)
1084072	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	MENSTRUATION INDUCTION EFFECT	Salvia miltiorrhiza (LAMIACEAE)
667830	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
266508	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTASHINONE,NEO: OLEOYL:
951266	PHARMACOLOGY OF EXTRACT - IN VIVO	BARBITURATE POTENTIATION	Salvia miltiorrhiza (LAMIACEAE)
33418	PRESENT IN (REVIEW)		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE IITANSHINOL IITANSHINONE ITANSHINOL ICRYPTOTANSHINONETOCOPHEROL,ALPHA:
300655	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1198957	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
69277	PHARMACOLOGY OF EXTRACT - IN HUMANS	COLLAGEN BIOSYNTHESIS INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374700	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
939084	CLINICAL STUDIES	ANALGESIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374755	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,1-2-DIHYDRO:
113690	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIOXIDE,NOR:
374768	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,3-HYDROXY-METHYLENE:
670764	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
1190967	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	DANSHEXINKUN ATANSHINONATE,METHYL:
663397	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1076946	TRADITIONAL MEDICINEEFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	ANTISCLERODERMA ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
868602	SPECTROPHOTOMETRIC ASSAY OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE
492263	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOTENSIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
958429	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTINEPHRITIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
665995	PHARMACOLOGY OF COMPOUND - IN VITRO	HEXOSAMINIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
809636	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIPROLIFERATION ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
669867	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Salvia miltiorrhiza (LAMIACEAE)
1129091	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Salvia miltiorrhiza (LAMIACEAE)
477995	PHARMACOLOGY OF EXTRACT - IN VIVO	PHARMACOKINETIC STUDY OF	Salvia miltiorrhiza (LAMIACEAE)
377608	MEDICINAL FOLKLORE REPORTED FOR	SKIN IMPROVEMENT EFFECT	Salvia miltiorrhiza (LAMIACEAE)
374748	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL B
368330	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	ROSMARIQUINONE
374726	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1293593	PHARMACOLOGY OF COMPOUND - IN VITRO	APOPTOSIS INDUCTION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
660750	PHARMACOLOGY OF EXTRACT - IN VITRO	INTERCELLULAR COMMUNICATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374703	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL A
1147957	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINQUINONE,METHYLENE:TANSHINONE,CRYPTO:TANSHINONE II-ATANSHINONE I
374689	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
956671	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
929499	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOL
821441	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURETLC DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID A
1280024	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374737	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,15-16-DIHYDRO:
116397	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
956721	PHARMACOLOGY OF EXTRACT - IN VIVO	SUBSTANCE P LEVELS DECREASED	Salvia miltiorrhiza (LAMIACEAE)
346178	PHARMACOLOGY OF EXTRACT - IN VIVO	PHARMACOKINETIC STUDY OF	Salvia miltiorrhiza (LAMIACEAE)
1313244	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	PHARMACOKINETIC STUDY OF	Salvia miltiorrhiza (LAMIACEAE)
1295287	PHARMACOLOGY OF EXTRACT - IN VITRO	PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374791	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONIC ACID METHYL ESTER
104047	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	MILTIONONE II
198958	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
639386	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374780	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL CTANSHINDIOL B
787357	PHARMACOLOGY OF EXTRACT - IN VITRO	CALCIUM TRANSIENT INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
100899	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIUREMIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
1280031	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
800598	PHARMACOLOGY OF EXTRACT - IN VIVO	PROTEIN DOWNREGULATION ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
599908	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1000389	PHARMACOLOGY OF EXTRACT - IN VIVO	VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1130421	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1311736	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTISPASMOLYTIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-ACRYPTOTANSHINONE
374711	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL A
418079	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED	ANTINEPHROTOXIC	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID
1153733	PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSREVIEW OF	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
367074	PHARMACOLOGY OF COMPOUND - IN VITRO	12-HETE SYNTHESIS STIMULATION	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID A,ACETYL:
663411	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE II-A
973321	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
932512	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
211119	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
374690	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE,DEHYDRO:
897434	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	LIVER EFFECTS(UNSPECIFIED)	Salvia miltiorrhiza (LAMIACEAE)
686491	PHARMACOLOGY OF EXTRACT - IN VITRO	LEUKOCYTE PROLIFERATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1073082	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIANGINAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
96830	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	SALVIOLONE
973128	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
117623	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHENSPIROKETALLACTONE,EPI:
421577	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SUGIOL
1086910	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374678	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
458679	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIACNE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
266510	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTASHINONE,NEO: OLEOYL:
1122842	QUANTITATIVE DATAIDENTIFICATION OFQUANTITATIVE DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
530772	PHARMACOLOGY OF EXTRACT - IN VIVO	MUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374714	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	PRZEWAQUINONE A
596529	PHARMACOLOGY OF EXTRACT - IN VIVO	LIPID PEROXIDE FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
897623	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
670760	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID
1278267	PHARMACOLOGY OF EXTRACT - IN VIVO	CARDIOVASCULAR EFFECTS(UNSPECIFIED)	Salvia miltiorrhiza (LAMIACEAE)
962898	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED	RENAL FUNCTION IMPROVEMENT	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID MG SALT
889874	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE V
741766	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOCHROME C RELEASE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
1153634	PHARMACOLOGY OF EXTRACT - IN VITRO	SMOOTH MUSCLE RELAXANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1153686	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
682703	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIVIRAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID
1280042	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
968714	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
452390	PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOLTANSHINONE VITANSHINONE II-ATANSHINONE ITANSHINONE VTANSHINONE I,DIHYDRO:TANSHINONE II-BCRYPTOTANSHINONE
374785	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL C
374779	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL CTANSHINDIOL B
951259	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTAMATE-OXALOACETATE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
660748	PHARMACOLOGY OF EXTRACT - IN VITRO	INTERCELLULAR COMMUNICATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
802938	PLANT TISSUE CULTURE MARKER CODEVOUCHER SPECIMEN REPORTED FORBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
374759	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,METHYLENE:
103087	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	RO-090680
638714	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIALLERGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
782633	PHARMACOLOGY OF EXTRACT - IN VITRO	TRANSFORMING GROWTH FACTOR-BETA RELEASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
802479	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL GROWTH ENHANCEMENT EFFECT	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
889879	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE VI
116401	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
731947	PHARMACOLOGY OF EXTRACT - IN VITRO	NUCLEAR FACTOR KAPPA-BETA INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
75374	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	DANSHENXINKUN D
89512	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B,ISO:
1084036	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	PROTOCATECHUALDEHYDE
1143144	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
173094	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE,ISO: I-KETO:
738993	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTITHROMBOTIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
741660	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)	SALVIAMILTAMIDE
69395	PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
607517	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1045911	TLC DATA REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
130103	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	FERULIC ACID,ISO:
595362	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
733982	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374707	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
374722	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
1155894	PHARMACOLOGY OF EXTRACT - IN VITRO	ANGIOTENSIN-CONVERTING ENZYME INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
968717	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
1288637	PHARMACOLOGY OF EXTRACT - IN VITRO	METALLOPROTEASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
496088	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Salvia miltiorrhiza (LAMIACEAE)	CAFFEIC ACID
1147542	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTICOAGULANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
707984	PHARMACOLOGY OF EXTRACT - IN VITRO	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
73207	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	ANTIOXYTOCIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
103084	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
897639	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
374733	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,15-16-DIHYDRO:
53241	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIANGINAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1116904	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
798165	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	PRZEWAQUINONE A
944823	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM ION UPTAKE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)	TRANSHINONE VI
663401	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)
211111	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	DANSHENOL B
1280035	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
371796	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERCHOLESTEROLEMIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
840400	PHARMACOLOGY OF COMPOUND - IN VITROCARCINOGENIC DATA (MARKER CODE)TOXICITY MARKER CODE	MUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II
802761	PHARMACOLOGY OF EXTRACT - IN VITRO	GABA RECEPTOR BINDING STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
602022	PHARMACOLOGY OF COMPOUND - IN VITRO	SPASMOLYTIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	BLECHINIC ACID,8-EPI:
589897	PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE
897632	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
116396	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
951812	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL C
1073086	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	CORONARY VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
387188	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
897621	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
374769	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL A
211115	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
670750	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CAFFEIC ACID
421573	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,NOR:
266514	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	DANSHENXINKUN A,OLEOYL:
895427	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENYL CYCLASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID MONOMETHYL ESTER
199221	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,DIHYDRO:
769547	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
421584	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOLSALVILENONE
1141136	PHARMACOLOGY OF EXTRACT - IN HUMANS	INTRAOCULAR PRESSURE REDUCTION	Salvia miltiorrhiza (LAMIACEAE)
198969	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	PRZEWAQUINONE A
103086	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	RO-090680
1097109	EFFECTS DUE TO A COMBINATION OF DRUGSANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS	ABORTIFACIENT EFFECT	Salvia miltiorrhiza (LAMIACEAE)
404130	IDENTIFICATION IN BY TLC		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
660747	PHARMACOLOGY OF EXTRACT - IN VITRO	INTERCELLULAR COMMUNICATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
68204	HERBAL INTERACTIONS		Salvia miltiorrhiza (LAMIACEAE)
1143215	PHARMACOLOGY OF EXTRACT - IN VIVO	METABOLISM OF	Salvia miltiorrhiza (LAMIACEAE)
421576	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,NOR:
1181138	PHARMACOLOGY OF EXTRACT - IN VIVO	CHRONOTROPIC EFFECT NEGATIVE	Salvia miltiorrhiza (LAMIACEAE)
470477	PHARMACOLOGY OF EXTRACT - IN VIVO	RENAL FUNCTION IMPROVEMENT	Salvia miltiorrhiza (LAMIACEAE)
751806	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID BLITHOSPERMIC ACID B,MAGNESIUM:
1153630	PHARMACOLOGY OF EXTRACT - IN VIVO	BRADYCARDIA ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
638713	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
897624	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
367075	PHARMACOLOGY OF COMPOUND - IN VITRO	ARACHIDONIC ACID RELEASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID A,ACETYL:
374718	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	PRZEWAQUINONE A
932513	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIOXIDANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	DANSHENXINKUN BTANSHINQUINONE,METHYLENE:TANSHINONETANSHINONE II-BCRYPTOTANSHINONE
67011	PHARMACOLOGY OF EXTRACT - IN HUMANS	NEUROPROTECTANT EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1065877	IDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,METHYLENE:TANSHINONE II-ATANSHINONE I
663412	PHARMACOLOGY OF COMPOUND - IN VITRO	FREE RADICAL FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE II-A
1092647	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	CNS DEPRESSANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
802756	PHARMACOLOGY OF EXTRACT - IN VITRO	DOPAMINERGIC(D2) RECEPTOR BINDING ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374684	EFFECTS DUE TO A COMBINATION OF DRUGSMEDICINAL FOLKLORE REPORTED FOR	CNS DEPRESSANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
925782	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERCHOLESTEROLEMIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1007419	PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION AND IDENTIFICATION OF	TOXICITY ASSESSMENT(QUANTITATIVE)	Salvia miltiorrhiza (LAMIACEAE)	CATECHOLALDEHYDE
1167321	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
788239	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
374740	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
362534	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED	DRUG ADDICTION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONETANSHINONE II-A
497272	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
732001	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIENDOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1198960	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
968706	PHARMACOLOGY OF COMPOUND - IN VITRO	COMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
374715	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
893104	IDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-ATANSHINONE I-ACRYPTOTANSHINONE
497953	PHARMACOLOGY OF COMPOUND - IN VITRO	LYSYL OXIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
929498	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOL
1086909	IDENTIFICATION IN BY TLCQUANTITATIVE DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-ATANSHINONE ITANSHIQUINONE,METHYL:
1070725	PHARMACOLOGY OF EXTRACT - IN VITRO	SMOOTH MUSCLE STIMULANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1105272	PHARMACOLOGY OF EXTRACT - IN VITROCARCINOGENIC DATA (MARKER CODE)	MUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
934910	PLANT TISSUE CULTURE MARKER CODE		Salvia miltiorrhiza (LAMIACEAE)
1171072	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374691	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
962292	QUANTITATIVE DATAIDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
348211	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
33419	MEDICINAL FOLKLORE REPORTED FOR	CNS DEPRESSANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
722925	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAIDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I-A
92798	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORNEW COMPOUND - ARTIFACTISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID C
374763	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL A
1093572	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPOXIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
897635	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
1208109	PHARMACOLOGY OF EXTRACT - IN VIVO	RENAL FUNCTION IMPROVEMENT	Salvia miltiorrhiza (LAMIACEAE)
400835	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Salvia miltiorrhiza (LAMIACEAE)	CAFFEIC ACIDLITHOSPERMIC ACID BPROTOCATECHUALDEHYDEROSMARINIC ACIDDANSHENSU
1122816	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHENSU
663416	PHARMACOLOGY OF COMPOUND - IN VITRO	FREE RADICAL FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID,DIMETHYL:
897628	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
377610	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
895421	PHARMACOLOGY OF EXTRACT - IN VITRO	ADENYL CYCLASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
211122	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	DANSHEXINKUN A,(-):
140456	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONAL
711947	PHARMACOLOGY OF EXTRACT - IN VIVO	ASPARTATE AMINOTRANSFERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
929504	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TASHINONE,1-DEHYDRO:
741659	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIAMILTAMIDE
368337	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIOXIDANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II, DIHYDRO:PHENANTHRENE-9-10-DIONE
780577	PHARMACOLOGY OF EXTRACT - IN VIVO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
808303	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,DIHYDRO:
33420	MEDICINAL FOLKLORE REPORTED FOR	CNS DEPRESSANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
741662	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B DIMETHYL ESTER
421587	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOLSALVILENONE
1284441	PHARMACOLOGY OF EXTRACT - IN VIVO	ETHANOL ABSORPTION DECREASED	Salvia miltiorrhiza (LAMIACEAE)
973127	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
886621	CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOL
1140210	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPERTENSIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
663405	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOPROTECTIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
848175	PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOL
1280027	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1116908	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II
1167324	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
684458	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
642993	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID METABOLISM EFFECTS	Salvia miltiorrhiza (LAMIACEAE)
374751	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,METHYLENE:
1160238	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
807238	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTEOCLAST FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
421581	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	SALVILENONE
1280038	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
951261	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
441266	PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOLTANSHINONE VITANSHINONE II-ATANSHINONE ITANSHINONE VTANSHINONE I,DIHYDRO:AGROPINETANSHINONE II-BCRYPTOTANSHINONEMANNOPINE A
652562	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
416269	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	ESTROGENIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
211108	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	DANSHENOL A
797925	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIOTOTOXICITY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1290923	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
1187472	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374756	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,1-2-DIHYDRO:
757322	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERPLASIA ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1004297	IDENTIFICATION OFQUANTITATIVE DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	TANSHINQUINONE,METHYLENE:TANSHINONE II-ATANSHINONE I
374774	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL B
1116910	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
374695	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE,DEHYDRO:
868251	BIOSYNTHESISABSOLUTE CONFIGURATION DETERMINEDISOLATION FROM DURING BIOSYNTHESIS STUDY		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
1235183	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	MENSTRUATION INDUCTION EFFECT	Salvia miltiorrhiza (LAMIACEAE)
194392	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	TANSHINKETOLACTONE
300659	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,15-16-DIHYDRO:
758536	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1298250	EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES	IMMUNOMODULATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
199226	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
374745	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL B
211118	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
490613	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPOACUSIS ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374744	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
665991	PHARMACOLOGY OF COMPOUND - IN VITRO	HEXOSAMINIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,15-16-DIHYDRO:
677792	PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISQUANTITATIVE DATA REPORTEDISOLATION FROM DURING BIOSYNTHESIS STUDY		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID BTANSHINONE II-ATANSHINONE IROSMARINIC ACIDCRYPTOTANSHINONE
680143	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
951815	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIHYPOXIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE,DEHYDRO:
670754	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID
577820	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
807686	PHARMACOLOGY OF COMPOUND - IN VITRO	TYROSINASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID METHYL ESTER
104051	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
788241	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
663398	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)
374790	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONIC ACID METHYL ESTER
663417	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOPROTECTIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID,DIMETHYL:
951810	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL B
741765	PHARMACOLOGY OF EXTRACT - IN VITRO	MITOCHONDRIAL INACTIVATION	Salvia miltiorrhiza (LAMIACEAE)
809518	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
89509	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B,ISO:
1303235	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID SYNTHESIS INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE IIA
679871	PHARMACOLOGY OF EXTRACT - IN VIVO	ALDOSTERONE DECREASE	Salvia miltiorrhiza (LAMIACEAE)
69276	PHARMACOLOGY OF EXTRACT - IN HUMANS	LIPID PEROXIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
199229	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
377614	PHARMACOLOGY OF EXTRACT - IN VIVO	MYELOPEROXIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
646306	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
2642	PHARMACOLOGY OF EXTRACT - IN VIVO	VITAMIN ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1070726	PHARMACOLOGY OF EXTRACT - IN VITRO	SMOOTH MUSCLE RELAXANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
861835	QUANTITATIVE DATAIDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1301351	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOPROTECTIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
808307	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
1293566	PRESENT IN (REVIEW)		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
676921	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
918644	PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE V
1093571	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
682705	PHARMACOLOGY OF COMPOUND - IN VITRO	HIV-1 INTEGRASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
1187471	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1073088	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	CORONARY VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
670756	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID
667829	PHARMACOLOGY OF EXTRACT - IN VITRO	APOPTOSIS INDUCTION	Salvia miltiorrhiza (LAMIACEAE)
953001	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTAMATE-PYRUVATE-TRANSAMINASE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
1280023	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
897629	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
354102	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
109449	PMR SPECTRUM REPORTEDCOMPLETE SYNTHESIS REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	ARUCADIOL
374775	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL C
680858	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOCHROME P450 INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
199227	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
889873	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,DIHYDRO:
951267	PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1190970	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	FLAVANONE,3'-5-DIHYDROXY-4'-7-DIMETHOXY:
96833	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	ARUCADIOL
67629	PHARMACOLOGY OF EXTRACT - IN HUMANS	DRUG INTERACTION	Salvia miltiorrhiza (LAMIACEAE)
198957	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
669869	PHARMACOLOGY OF EXTRACT - IN VIVO	LOCOMOTOR ACTIVITY DECREASE	Salvia miltiorrhiza (LAMIACEAE)
438670	IDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE ICRYPTOTANSHINONE
741657	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID DIMETHYL ESTER
968704	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
1175970	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
351251	PHARMACOLOGY OF EXTRACT - IN VITRO	BETA-GLUCURONIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1153732	PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSREVIEW OF	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374710	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL A
607521	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
703987	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIOXIDANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
686492	PHARMACOLOGY OF EXTRACT - IN VITRO	LEUKOCYTE PROLIFERATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1290918	PHARMACOLOGY OF COMPOUND - IN VITRO	DIACYLGLYCEROL ACYLTRANSFERASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,15-16-DIHYDRO:
670758	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID
968711	PHARMACOLOGY OF EXTRACT - IN VITRO	COMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
470021	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
374679	MEDICINAL FOLKLORE REPORTED FOR	ANTIANGINAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
802755	PHARMACOLOGY OF EXTRACT - IN VITRO	DOPAMINERGIC(D1) RECEPTOR BINDING ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
964451	IDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL ATANSHINQUINONE,METHYLENE:FERRUGINOLTANSHINONE VITANSHINQUINONE,1-2-DIHYDRO:TANSHINONE II-ATANSHINONE ITANSHINONE I,DIHYDRO:TANSHINDIOL CMILTIRONE,DEHYDRO:TANSHINONE II-BCRYPTOTANSHINONETANSHINDIOL B
680147	PHARMACOLOGY OF EXTRACT - IN VITRO	RECEPTOR BINDING STIMULANT	Salvia miltiorrhiza (LAMIACEAE)
266513	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	DANSHENXINKUN A,OLEOYL:
6872	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	SALVIOL
300658	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
1295288	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)
211121	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
665989	PHARMACOLOGY OF COMPOUND - IN VITRO	HEXOSAMINIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
639383	PHARMACOLOGY OF EXTRACT - IN VITRO	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1313243	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONES
374682	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	ANTIOXYTOCIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
66831	CLINICAL STUDIES	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1076451	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINQUINONE,METHYLENE:TANSHINQUINONE,1-2-DIHYDRO:
421583	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOLSALVILENONE
682704	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
266509	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTASHINONE,NEO: OLEOYL:
1181142	PHARMACOLOGY OF EXTRACT - IN VITRO	VASOCONSTRICTOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
681717	REVIEW OF		Salvia miltiorrhiza (LAMIACEAE)
374786	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONIC ACID METHYL ESTER
1190843	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOAZOTEMIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	CAFFEIC ACID TETRAMER,DIHYDRO:
24979	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	UTERINE RELAXATION EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1013519	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED		Salvia miltiorrhiza (LAMIACEAE)	PROTOCATECHUALDEHYDE
263392	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)	SALVIAMILTAMIDE
665994	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
198962	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,METHYLENE:
800599	PHARMACOLOGY OF EXTRACT - IN VIVO	PROTEIN UP-REGULATION STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
1178031	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	DIURETIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
948482	PHARMACOLOGY OF EXTRACT - IN VIVO	ALLOGRAFT REJECTION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
944825	PHARMACOLOGY OF COMPOUND - IN VITRO	INOTROPIC EFFECT POSITIVE	Salvia miltiorrhiza (LAMIACEAE)	TRANSHINONE VI
1102955	IDENTIFICATION IN BY GLCPLANT TISSUE CULTURE MARKER CODE		Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOL
1046398	PRODUCT DEVELOPMENT OF HERBAL EXTRACTISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)
421572	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,NOR:
1116912	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,1-2-DIHYDRO:
1007420	PHARMACOLOGY OF COMPOUND - IN HUMANS	ANTIANGINAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	CATECHOLALDEHYDE
368331	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIOXIDANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	ROSMARIQUINONEMILTIRONE I
897433	EFFECTS DUE TO A COMBINATION OF DRUGSANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIVIRAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
729307	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEIN KINASE C INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
363501	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	MYOCARDIAL INFARCTION TREATMENT	Salvia miltiorrhiza (LAMIACEAE)
173095	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-ATANSHINONE I,ISO: DIHYDRO:IMPERATORIN,ISO:DANSHEXINKUN BCRYPTOTANSHINONE,NEO: DEOXY:CRYPTOTANSHINONE
746275	PHARMACOLOGY OF EXTRACT - IN VITRO	APOPTOSIS INDUCTION	Salvia miltiorrhiza (LAMIACEAE)
1274221	PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONES
198965	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
644547	PHARMACOLOGY OF COMPOUND - IN VITRO	MISCELLANEOUS EFFECTS	Salvia miltiorrhiza (LAMIACEAE)	LINOLENIC ACID
1198959	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
821442	MEDICINAL FOLKLORE REPORTED FOR	CARDIOVASCULAR EFFECTS(UNSPECIFIED)	Salvia miltiorrhiza (LAMIACEAE)
1311743	PRESENT IN (REVIEW)		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-ACRYPTOTANSHINONE
1303405	PHARMACOLOGY OF COMPOUND - IN VITRO	NEUROPROTECTANT EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
1304362	EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES	ANTIFATIGUE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
731922	PHARMACOLOGY OF EXTRACT - IN VIVO	ABSORPTION DECREASE EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1084035	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
832022	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	URSOLIC ACIDPROTOCATECHUIC ALDEHYDETANSHINONE I,DIHYDRO:FERULIC ACID,ISO:SITOSTEROL,BETA:CRYPTOTANSHINONEDAUCOSTEROLBAICALIN
718955	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
104048	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOL
1181145	PHARMACOLOGY OF EXTRACT - IN VITRO	VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
951263	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1280041	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
199223	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,DIHYDRO:
211110	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	DANSHENOL A
362533	PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS	DRUG ADDICTION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
127247	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID G
1181970	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTINEPHROTOXIC	Salvia miltiorrhiza (LAMIACEAE)
787356	PHARMACOLOGY OF EXTRACT - IN VITRO	CELL CONTRACTION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1280030	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
100898	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
809637	PHARMACOLOGY OF EXTRACT - IN VITRO	APOPTOSIS INDUCTION	Salvia miltiorrhiza (LAMIACEAE)
470020	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOLYTIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
669868	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Salvia miltiorrhiza (LAMIACEAE)
1275865	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
1129092	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Salvia miltiorrhiza (LAMIACEAE)
1073083	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIANGINAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
670751	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	CAFFEIC ACID
895424	CMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID METHYL ESTER
964437	MASS-SPECTRAL FRAGMENTATION REPORTEDTLC DATA REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINDIOL AOLEANOLIC ACIDPRZEWAWUINONR BTANSHINONE,METHYLENE:PRZEWANOIC ACID BTANSHINONE,NOR:TANSHINONE II-ATANSHINONE IDANSHENXINKUN DTANSHINDIOL CDANSHEXINKUN ATANSHINONE,HYDROXY:TANSHINONE II-BCRYPTOTANSHINONETANSHINDIOL BTANSHINONE,DIHYDRO:PRZEWAQUINONE APRZEWANOIC ACID A
140463	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONIC ACID METHYL ESTER
644545	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LINOLENIC ACID
944821	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TRANSHINONE VI
660751	PHARMACOLOGY OF EXTRACT - IN VITRO	INTERCELLULAR COMMUNICATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
374704	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
1280029	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
530771	PHARMACOLOGY OF EXTRACT - IN VITRO	MUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
540264	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET ACTIVATING FACTOR BINDING INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
711946	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTITUMOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
935213	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTISHOCK EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1153735	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
374732	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
807237	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
374685	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
639387	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
670749	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CAFFEIC ACID
663421	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOPROTECTIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	LACTAMIDE,3-(3-4-DIHYDROXY-PHENYL):
682529	PHARMACOLOGY OF EXTRACT - IN VIVO	NITRIC OXIDE SYNTHASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
670759	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID
180895	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	DANSHANSPIROKETAL-LACTONE,EPI:
665990	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,15-16-DIHYDRO:
663402	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
848174	PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOLCRYPTOTANSHINONE
198966	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,15-16-DIHYDRO:
670763	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
351249	PHARMACOLOGY OF EXTRACT - IN VITRO	GLUCOSIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
932511	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIOXIDANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
89510	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B,ISO:
780573	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
368335	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
1288237	PHARMACOLOGY OF COMPOUND - IN VIVO	PHARMACOKINETIC STUDY OF	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
374694	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE,DEHYDRO:
117620	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOACETALIDE
374683	EFFECTS DUE TO A COMBINATION OF DRUGSMEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1280040	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
956670	PHARMACOLOGY OF EXTRACT - IN VIVO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
421578	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	SUGIOL
679869	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERTENSIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
766326	PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-ATANSHINONE ITANSHINONE I,DIHYDRO:CRYPTOTANSHINONE
656860	PHARMACOLOGY OF EXTRACT - IN VITRO	PROLYL ENDOPEPTIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1093569	EFFECTS DUE TO A COMBINATION OF DRUGSMEDICINAL FOLKLORE REPORTED FOR	ANTIANGINAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
791036	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
1288636	PHARMACOLOGY OF EXTRACT - IN VITRO	ORNITHINE DECARBOXYLASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1317243	PRESENT IN (REVIEW)		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
1153633	PHARMACOLOGY OF EXTRACT - IN VITRO	VASOCONSTRICTOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
929496	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE
1282787	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID BPROTOCATECHUALDEHYDEDANSHENSU
473708	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
813454	PHARMACOLOGY OF EXTRACT - IN VIVO	VASODILATOR ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
421586	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	FERRUGINOLSALVILENONE
497952	PHARMACOLOGY OF COMPOUND - IN VITRO	PROLINE HYDROXYLASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
968709	PHARMACOLOGY OF EXTRACT - IN VITRO	COMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
497271	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
96834	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	SALVIOXIDE,NOR:
1280034	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
951814	IDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE,DEHYDRO:
680144	PHARMACOLOGY OF EXTRACT - IN VITRO	RECEPTOR BINDING STIMULANT	Salvia miltiorrhiza (LAMIACEAE)
840401	PHARMACOLOGY OF COMPOUND - IN VITROCARCINOGENIC DATA (MARKER CODE)TOXICITY MARKER CODE	MUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II
973322	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374750	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,1-2-DIHYDRO:
782632	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIPROLIFERATION ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
67628	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTICOAGULANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
889878	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
1157393	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
895428	CMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID DIMETHYL ESTER
953772	PHARMACOLOGY OF EXTRACT - IN VITRO	CHOLECYSTOKININ RECEPTOR BINDING EFFECT	Salvia miltiorrhiza (LAMIACEAE)
374708	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
951260	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTAMATE-OXALOACETATE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
636109	VOUCHER SPECIMEN REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)
374721	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-B
607518	MASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
103083	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	SALVINONE
595363	PHARMACOLOGY OF EXTRACT - IN VITRO	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
421575	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,NOR:
1290922	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTINEPHROTOXIC	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B
1311735	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	ANTISPASMOLYTIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374696	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE,DEHYDRO:
897625	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,DIHYDRO:
1297172	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	ANTIALCOHOLIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
73208	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	FEMALE DISORDERS(UNSPECIFIED)	Salvia miltiorrhiza (LAMIACEAE)
753448	PHARMACOLOGY OF EXTRACT - IN VIVO	RENAL FUNCTION IMPROVEMENT	Salvia miltiorrhiza (LAMIACEAE)
741658	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID DIMETHYL ESTER
663413	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOPROTECTIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE II-A
670745	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	LITHOSPERMIC ACID B,MAGNESIUM:
1190968	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE IITANSHINQUINONE,METHYLENE:
1167322	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
944824	PHARMACOLOGY OF COMPOUND - IN VITRO	CREATIN KINASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	TRANSHINONE VI
595405	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLC		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,DIHYDRO:
663406	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE II-A
670755	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE LEAKAGE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID
807683	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID
371797	PHARMACOLOGY OF EXTRACT - IN VIVO	LIPID PEROXIDE FORMATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
684601	PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
780578	PHARMACOLOGY OF EXTRACT - IN VIVO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
953002	PHARMACOLOGY OF EXTRACT - IN VIVO	LACTATE DEHYDROGENASE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
374743	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
178757	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	DANSHENSPIROKETALLACTONE II
1080990	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIANGINAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
113688	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	MILTIOPOLONE
363790	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTINEPHROTOXIC	Salvia miltiorrhiza (LAMIACEAE)
802758	PHARMACOLOGY OF EXTRACT - IN VITRO	SEROTONIN (5-HT) RECEPTOR BINDING ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
348209	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
89508	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE,NEO:
788242	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,METHYLENE:
438667	PHARMACOLOGY OF EXTRACT - IN VITRO	ADENYL CYCLASE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
211116	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I
104057	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	STIGMASTEROL
804352	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Salvia miltiorrhiza (LAMIACEAE)
1275124	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	PRZEWAQUINONE A
641389	PHARMACOLOGY OF EXTRACT - IN VIVO	NEUROPROTECTANT EFFECT	Salvia miltiorrhiza (LAMIACEAE)
665986	PHARMACOLOGY OF EXTRACT - IN VITRO	HEXOSAMINIDASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
934911	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOTENSIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
73205	MEDICINAL FOLKLORE REPORTED FOR	BLOOD SYSTEM EFFECTS(UNSPECIFIED)	Salvia miltiorrhiza (LAMIACEAE)
92800	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	ROSMARINIC ACID
113686	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	MILTIOPOLONE
1280039	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
897636	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
741764	PHARMACOLOGY OF EXTRACT - IN VITRO	THIOL CONTENT DECREASE	Salvia miltiorrhiza (LAMIACEAE)
199219	PHARMACOLOGY OF COMPOUND - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	DANSHENOL A
757323	PHARMACOLOGY OF EXTRACT - IN VIVO	MONOCYTE CHEMOTACTIC PROTEIN-1 GENE EXPRESSION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
669870	PHARMACOLOGY OF EXTRACT - IN VIVO	ANALGESIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
652563	PHARMACOLOGY OF EXTRACT - IN VITRO	TUMOR NECROSING FACTOR INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1301350	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID B
235548	PMR SPECTRUM REPORTEDPLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Salvia miltiorrhiza (LAMIACEAE)	DANSHENXINKUN B
929503	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	MILTIRONE,1-DEHYDRO:
735090	REVIEW OF		Salvia miltiorrhiza (LAMIACEAE)
758537	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
374719	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINOL BPRZEWAQUINONE A
527356	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	PROTOCATECHUALDEHYDETANSHINONE IROSMARINIC ACIDSUCCINIC ACIDFERULIC ACID,ISO:CRYPTOTANSHINONE
584267	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
140457	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONAL
808304	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
496089	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID A
1282382	PHARMACOLOGY OF EXTRACT - IN VITRO	RECEPTOR REGULATING EFFECT(UNSPECIFIED)	Salvia miltiorrhiza (LAMIACEAE)
968715	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
964810	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIISCHEMIC EFFECT	Salvia miltiorrhiza (LAMIACEAE)
953000	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTAMATE-OXALOACETATE-TRANSAMINASE STIMULATION	Salvia miltiorrhiza (LAMIACEAE)
67502	REVIEW OF		Salvia miltiorrhiza (LAMIACEAE)
1190966	ISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHEXINKUN ATANSHINONATE,METHYL:
932518	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHENXINKUN B
116399	CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	DANSHEXINKUN B
1147720	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
601039	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I-A
602021	PHARMACOLOGY OF COMPOUND - IN VITRO	SPASMOLYTIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	BLECHINIC ACID,8-EPI:
367071	PHARMACOLOGY OF COMPOUND - IN VITRO	THROMBOXANE B-2 SYNTHESIS INHIBITION	Salvia miltiorrhiza (LAMIACEAE)	SALVIANOLIC ACID A,ACETYL:
374754	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE 1,1-2-DIHYDRO:
642992	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID METABOLISM EFFECTS	Salvia miltiorrhiza (LAMIACEAE)
1105273	PHARMACOLOGY OF EXTRACT - IN VITROCARCINOGENIC DATA (MARKER CODE)	MUTAGENIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
779923	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Salvia miltiorrhiza (LAMIACEAE)
832023	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE I,ISO: DIHYDRO:
348210	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	GLUCOSE ABSORPTION INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1143143	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
962293	QUANTITATIVE DATAIDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,METHYLENE:
199220	UV SPECTRUM GIVEN FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Salvia miltiorrhiza (LAMIACEAE)	DANSHENOL B
421580	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	SUGIOL
374764	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	TANSHIQUINONE,3-HYDROXY-METHYLENE:
861885	IDENTIFICATION IN BY TLC		Salvia miltiorrhiza (LAMIACEAE)	TANSHINONE,CRYPTO:
738994	PHARMACOLOGY OF EXTRACT - IN VIVO	TISSUE PLASMINOGEN ACTIVATOR INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
198968	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Salvia miltiorrhiza (LAMIACEAE)	PRZEWAQUINONE A
1073027	PHARMACOLOGY OF EXTRACT - IN VIVO	CNS DEPRESSANT ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
211109	PHARMACOLOGY OF EXTRACT - IN VITRO	ALDOSE REDUCTASE INHIBITION	Salvia miltiorrhiza (LAMIACEAE)
1181139	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOTENSIVE ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)
1045912	PHARMACOKINETIC/BIOAVAILABITY STUDYPHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)	CRYPTOTANSHINONE
377611	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Salvia miltiorrhiza (LAMIACEAE)

Experiments for taxon Salvia miltiorrhiza (LAMIACEAE)

Experiments (1232 results)

Filters

Worktypes (55)

Pharmacology (234)

Compounds (193)

Organisms (300)